Free Trial
→ 'I'm risking my reputation on this' (From Crypto 101 Media) (Ad) Free LEGN Stock Alerts

Legend Biotech (LEGN) SEC Filings & 10K Form

Legend Biotech logo
$35.35 -0.56 (-1.56%)
Closing price 02:47 PM Eastern
Extended Trading
$35.35 0.00 (0.00%)
As of 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Legend Biotech SEC Filings

Export to Excel
DateFilerForm TypeView
06/30/2025
3:05 PM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2025
10:21 AM		Casey Patrick John (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2025
9:31 AM		Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
3:23 PM		Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
9:05 AM		Legend Biotech (Subject)
Sanders Corazon D. (0001796536) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
10:18 AM		Casey Patrick John (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
9:03 AM		FMR LLC (Filed by)
Legend Biotech (Subject)
Form SCHEDULE 13G/A
06/05/2025
7:22 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2025
10:00 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2025
8:00 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2025
6:00 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
7:31 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2025
10:06 AM		Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2025
6:30 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2025
2:47 PM		Legend Biotech (Subject)
Yeung Jessie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2025
2:41 PM		Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2025
11:15 AM		Legend Biotech (Subject)
Sanders Corazon D. (0001796536) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
10:42 AM		Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
6:00 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
8:44 AM		Legend Biotech (Subject)
Form SCHEDULE 13G/A
01/22/2025
6:30 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
3:01 PM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2025
2:14 PM		Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
8:48 AM		Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
8:59 AM		Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
3:01 PM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
6:35 PM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
2:08 PM		Heyman Tomas J. (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
7:46 AM		Legend Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/12/2024
6:03 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
8:10 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
7:00 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
6:30 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:35 PM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
2:30 PM		Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:43 PM		Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
9:46 AM		Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
7:01 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
6:30 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2024
6:01 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/26/2024
6:00 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
"I'm risking my reputation on this" (Ad)

Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.

Claim your FREE copy of Crypto Revolution now.
07/17/2024
6:30 AM		Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:LEGN) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners
Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
Timothy Sykes | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...
Porter & Company | Sponsored
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...
Crypto 101 Media | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...
Brownstone Research | Sponsored